{
  "entities": {
    "activities": {
      "5a5b2221-2342-41b8-b160-01cbd553444b": "Alcohol History",
      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c": "Antineoplastic therapies since discontinuation of study treatment",
      "036b4fc1-ad14-40c7-9936-5b8fc83fbbc6": "Blood Draw",
      "56d1da04-0d44-4564-8900-9abc54245746": "Computed Tomography",
      "4f50e206-c67f-461f-9f6e-cdf8e05e7cd9": "Demography",
      "96204503-e3ea-4d1c-aa32-b0946d94a797": "Diagnosis and extent of cancer",
      "b4c26fa7-6172-464c-88ad-03a56caa742e": "Disposition Assessment (at the end of each study phase)",
      "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d": "Drug Supply (IRT)",
      "7df28861-2961-4a5a-81bc-0dbe73108d4a": "EORTC QLQ-C30",
      "2ca12bf7-9b65-4ed9-9e88-0a518ce57ab8": "EQ-5D-5L",
      "9ec5a58e-6897-4e61-8afe-7a5055228347": "Echocardiogram",
      "b2ec919d-614f-4702-8b38-4ca9bb21b3f3": "Electrocardiogram",
      "4c6654f0-323e-4c89-9ee8-358f5483f4f0": "FACT-M subscale (16 questions)",
      "07eae9fd-c41c-44cd-97c3-6da437a55a36": "HIV History",
      "883f288b-3ab8-4819-9751-402dfafb5733": "IRT Registration-Enrollment",
      "5051d041-f995-4db5-aef1-2ea47b9767d7": "Inclusion/exclusion",
      "2a3770f2-0428-4317-b3b8-f3887a145616": "Intravenous Infusion",
      "9d62d40e-4b94-4e85-8a6f-631aec067d40": "Magnetic Resonance Imaging",
      "bcef8e1b-af59-4704-8c3f-31e9fae38e10": "Newly acquired tumor tissue for central BRAF V600 mutation testing",
      "8337ba30-667c-47c0-9841-16add23c593a": "Ophthalmologic Examination",
      "74858707-e0da-4baa-988f-3d002f421daf": "Past and current medical conditions including cardiovascular medical history and risk factors",
      "26e1ab38-15d3-492e-bf2d-cfff6d02a07e": "Pharmacogenetic ICF",
      "66990db9-c6e7-4973-8cdf-0d8e423fd199": "Physical Examination",
      "24b84935-9db2-4fd0-b454-2a618ed8e408": "Physical Examination (complete)",
      "517a28f3-fc96-4d1d-97d0-728b5bf65bca": "Prior antineoplastic therapies (meds, surgery, radiation)",
      "05e514d8-27f8-41de-9c83-4c4ec7504867": "Smoking History",
      "a6a3ad74-a23e-4c63-96f2-8625abb982ea": "Study ICF",
      "b53dd21a-14ce-422d-ab3b-056ad4761c84": "Treatment beyond progression ICF",
      "4ecd5a76-3c41-46b4-a339-d162a5e85d97": "Tumor Biopsy",
      "87e5e1ca-2ac1-4a63-b01d-e33175190a43": "Tumor tissue (archival or new) for central BRAF V600 mutation testing",
      "e1933515-f8a1-4da3-8e6a-5c7ce6d3bb1d": "Urinalysis"
    },
    "plannedTimepoints": {},
    "encounters": {
      "d8011093-0f47-45ef-b9b7-7525de5f221e": "Cycle 1 Day 1",
      "fe95fe18-c4d4-4902-b4ed-9fa6cab34631": "Cycle 2 Day 1",
      "bb077b8f-52e1-4678-bda4-c71687b8c749": "Cycle 3 Day 1",
      "0cb82d63-fd32-4488-a817-37efc335ef04": "Subsequent Cycles Day 1",
      "b9959f8e-3246-4dd6-9c9d-8502aeabb907": "Cycle 1 Day 8",
      "500ebb45-0b00-4bd2-b993-a1b145ee4c3b": "Cycle 2 Day 8",
      "d49cd1dc-3bb8-4bda-b642-256db9088c8d": "Cycle 1 Day 15",
      "41d477ba-b7d1-4d8e-b931-0891871dfd25": "Cycle 2 Day 15",
      "21b94e4c-b610-4135-9e81-46cb787fde7b": "Cycle 3 Day 15",
      "445a0fea-bfbf-4b46-919a-d58d27ccc81a": "120-Day Safety Follow Up",
      "76d9b2d2-99aa-4d10-9cf4-37eab9945a92": "150-Day Safety Follow Up",
      "7b8beecd-d8ed-454e-a353-9a2ca8a18c5d": "30-Day Safety Follow Up",
      "93d04d45-49fb-42ec-8f65-7859e3bc0483": "60-Day Safety Follow Up",
      "767f3fdf-7511-4a3a-a531-b80885ece3a4": "90-Day Safety Follow Up",
      "d695260e-71d8-44af-aaaa-656b6aaef0af": "End of Post Treatment Follow Up",
      "05d414aa-4601-4f32-adb6-e06fdef4da5a": "End of Study Treatment (EoT)",
      "233680c1-370b-44fb-a5e8-74bd0d8e8797": "Screening (-28 to -1)",
      "86e942a9-ed50-4bb8-b863-4cad07a33b0a": "Survival Follow Up"
    },
    "epochs": {
      "c8beb933-cf47-4316-815a-e216abe6da62": "Screening/Baseline",
      "54e7585a-70b5-48dd-9fb7-327f24fd9e23": "Treatment (Cycle = 28 days)",
      "f82007d7-8606-4120-b073-7056f0173f13": "Follow-Up Period"
    },
    "activityGroups": {}
  },
  "cells": {
    "a6a3ad74-a23e-4c63-96f2-8625abb982ea|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "26e1ab38-15d3-492e-bf2d-cfff6d02a07e|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "883f288b-3ab8-4819-9751-402dfafb5733|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "b53dd21a-14ce-422d-ab3b-056ad4761c84|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "4f50e206-c67f-461f-9f6e-cdf8e05e7cd9|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "5051d041-f995-4db5-aef1-2ea47b9767d7|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "74858707-e0da-4baa-988f-3d002f421daf|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "96204503-e3ea-4d1c-aa32-b0946d94a797|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "5a5b2221-2342-41b8-b160-01cbd553444b|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "05e514d8-27f8-41de-9c83-4c4ec7504867|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "07eae9fd-c41c-44cd-97c3-6da437a55a36|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "517a28f3-fc96-4d1d-97d0-728b5bf65bca|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|7b8beecd-d8ed-454e-a353-9a2ca8a18c5d": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|93d04d45-49fb-42ec-8f65-7859e3bc0483": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|767f3fdf-7511-4a3a-a531-b80885ece3a4": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|445a0fea-bfbf-4b46-919a-d58d27ccc81a": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|76d9b2d2-99aa-4d10-9cf4-37eab9945a92": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|d695260e-71d8-44af-aaaa-656b6aaef0af": "both",
    "c95b7c00-7f03-4d7f-80ee-a65c9657f90c|86e942a9-ed50-4bb8-b863-4cad07a33b0a": "both",
    "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d|d8011093-0f47-45ef-b9b7-7525de5f221e": "both",
    "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d|fe95fe18-c4d4-4902-b4ed-9fa6cab34631": "both",
    "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d|bb077b8f-52e1-4678-bda4-c71687b8c749": "both",
    "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d|0cb82d63-fd32-4488-a817-37efc335ef04": "both",
    "b4c26fa7-6172-464c-88ad-03a56caa742e|05d414aa-4601-4f32-adb6-e06fdef4da5a": "both",
    "b4c26fa7-6172-464c-88ad-03a56caa742e|d695260e-71d8-44af-aaaa-656b6aaef0af": "both",
    "b4c26fa7-6172-464c-88ad-03a56caa742e|86e942a9-ed50-4bb8-b863-4cad07a33b0a": "both",
    "24b84935-9db2-4fd0-b454-2a618ed8e408|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "bcef8e1b-af59-4704-8c3f-31e9fae38e10|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "bcef8e1b-af59-4704-8c3f-31e9fae38e10|d8011093-0f47-45ef-b9b7-7525de5f221e": "both",
    "bcef8e1b-af59-4704-8c3f-31e9fae38e10|bb077b8f-52e1-4678-bda4-c71687b8c749": "both",
    "87e5e1ca-2ac1-4a63-b01d-e33175190a43|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "7df28861-2961-4a5a-81bc-0dbe73108d4a|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "2ca12bf7-9b65-4ed9-9e88-0a518ce57ab8|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both",
    "4c6654f0-323e-4c89-9ee8-358f5483f4f0|233680c1-370b-44fb-a5e8-74bd0d8e8797": "both"
  },
  "cellFootnotes": {},
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}